Latest Breaking News On - Ecog acrin e4112 trial - Page 1 : comparemela.com

Seema A. Khan, MD, discusses 5-year clinical outcomes from the ECOG-ACRIN E4112 trial, which is evaluating the use of MRI and a 12-gene expression assay to optimize local therapy for patients with ductal carcinoma in situ.

Seemaa khanNorthwestern university feinberg school of medicineBluhm family professor of cancer researchOptimizing local therapy usingGene expression assayPartnership withBluhm family professorCancer researchNorthwestern university feinberg schoolEcog acrin e4112 trialPatients with ductal carcinoma in situ